Cardiovascular Disease and NASH

Journal Title: Liver Research – Open Journal - Year 2015, Vol 1, Issue 2

Abstract

Non-alcoholic fatty liver disease (NAFLD) and Non-alcoholic steatohepatitis (NASH) are associated with cardiovascular events and Metabolic Syndrome (MetS). NAFLD is considered to be a hepatic manifestation of MetS and has become an important public health issue because of its high prevalence. It is currently being considered an independent Cardiovascular disease (CVD) risk factor. In this clinical review, we will briefly review the mechanisms linking NAFLD to the complement system, endothelial dysfunction and the atherosclerosis.

Authors and Affiliations

Erika Rabelo Forte de Siqueira

Keywords

Related Articles

Hepatic Myelopathy: Case Report and Review of the Literature

Background: Hepatic Myelopathy (HM) is a rare complication of chronic liver disease usually associated with extensive portosystemic shunt of blood, which has been created surgically or has occurred spontaneously, causing...

Non-Alcoholic Fatty Liver Disease: The Effect of Bile Acids and Farnesoid X Receptor Agonists on Pathophysiology and Treatment

Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic in light of its two predisposing factors, a surge in both obesity and diabetes rates with reports of between 70-80% of obese individuals in Western countr...

Pediatric Acute Liver Failure: Current Perspectives

It is well known that acute liver failure (ALF) in children is rare but potentially a life-threatening disorder. Its true incidence in the pediatric population is undetermined but is responsible for 10-15% of all pediatr...

“Cardiac Hepatopathy”: A Review of Liver Dysfunction in Heart Failure

The unique dual circulation of the liver confers relative protection against ischemic injury; however, low oxygen tension in the microcirculation (sinusoidal blood of the hepatic acinus) may render hepatocytes in zone 3...

Magnetic Resonance Elastography Comes of Age

Clinicians are always in search of a less invasive method of diagnosing and assessing a patient. Patients with liver cirrhosis are no exception. Liver cirrhosis is the end stage of many liver pathologies and knowledge of...

Download PDF file
  • EP ID EP556681
  • DOI 10.17140/LROJ-1-107
  • Views 147
  • Downloads 0

How To Cite

Erika Rabelo Forte de Siqueira (2015). Cardiovascular Disease and NASH. Liver Research – Open Journal, 1(2), 41-44. https://europub.co.uk/articles/-A-556681